CDC: Steep Rise in New HCV Infections Over Last Five Years

Share this content:
CDC: Steep Rise in New HCV Infections Over Last Five Years
CDC: Steep Rise in New HCV Infections Over Last Five Years

FRIDAY, May 12, 2017 (HealthDay News) -- Reports of new hepatitis C virus (HCV) infections in the United States nearly tripled over five years, reaching a 15-year high, according to the U.S. Centers for Disease Control and Prevention.

The number of reported cases rose from 850 in 2010 to 2,436 in 2015. However, nearly half of people who have the liver infection don't know it, so most new cases are never reported. The CDC estimates there were actually about 34,000 new HCV infections nationwide in 2015. The highest number of new infections were reported among 20- to 29-year-olds. Many stemmed from the growing use of injected drugs linked to the current opioid epidemic, CDC officials said.

Nearly 20,000 Americans died from HCV-related causes in 2015, and most were age 55 and older, according to the new report. Three-quarters of the 3.5 million Americans infected with HCV are baby boomers, born between 1945 and 1965. They are six times more likely to be infected than people in other age groups and have a much higher risk of death from the virus, the CDC said. Recent CDC studies also show that HCV infections are rising among women of childbearing age, putting a new generation at risk.

"We must reach the hardest-hit communities with a range of prevention and treatment services that can diagnose people with hepatitis C and link them to treatment. This wide range of services can also prevent the misuse of prescription drugs and ultimately stop drug use -- which can also prevent others from getting hepatitis C in the first place," Jonathan Mermin, M.D., director of the agency's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, said in a CDC news release.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Actemra to Treat Giant Cell Arteritis

FDA Approves Actemra to Treat Giant Cell Arteritis

New indication provides the first FDA-approved therapy specific to this type of vasculitis

Trends in Teen Binge Drinking Still Raise Concerns

Trends in Teen Binge Drinking Still Raise Concerns

Even though frequent binge drinking among adolescents has dropped in past 25 years

ATS: First Abx Rx Doesn't Work for 25 of Pneumonia Cases

ATS: First Abx Rx Doesn't Work for ~25% ...

One in four adult patients do not respond to initial prescription of antibiotic treatment

is free, fast, and customized just for you!

Already a member?

Sign In Now »